These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4797028)

  • 1. Polyacrylamide: an improved surface for cloning of primary tumors containing fibroblasts.
    Jones TL; Haskill JS
    J Natl Cancer Inst; 1973 Nov; 51(5):1575-80. PubMed ID: 4797028
    [No Abstract]   [Full Text] [Related]  

  • 2. A micro-colony-inhibition method for quantitation of tumor immunity.
    Haskill JS
    J Natl Cancer Inst; 1973 Nov; 51(5):1581-8. PubMed ID: 4762935
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative lung colony assay for tumor immunity in mice.
    Boone CW; Lundberg E; Orme T; Gillette R
    J Natl Cancer Inst; 1973 Nov; 51(5):1731-4. PubMed ID: 4357767
    [No Abstract]   [Full Text] [Related]  

  • 4. The development of cellular immunity to tumor cells.
    Cerilli J; Smith MC
    Surg Gynecol Obstet; 1972 May; 134(5):739-45. PubMed ID: 5064081
    [No Abstract]   [Full Text] [Related]  

  • 5. Concurrent and subsequent tumors in the same host: a model to evaluate the host tumor interaction.
    Mendiondo OA; Suit HD; Sedlacek RS
    Int J Radiat Oncol Biol Phys; 1980 Feb; 6(2):193-8. PubMed ID: 7390894
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies to spontaneous and methylcholanthrene-induced tumors in inbred mice.
    Pilch YH; Riggins RS
    Cancer Res; 1966 May; 26(5):871-5. PubMed ID: 5327323
    [No Abstract]   [Full Text] [Related]  

  • 7. Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.
    Vaage J
    Cancer Res; 1973 Aug; 33(8):1957-65. PubMed ID: 4720805
    [No Abstract]   [Full Text] [Related]  

  • 8. Variation of dihydrofolate reductase activity during in vitro and in vivo growth of sublines of L1210 lymphoma.
    Hillcoat BL
    J Natl Cancer Inst; 1971 Jan; 46(1):75-80. PubMed ID: 5546195
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on mice of a tumor resistant strain (X-Gf). 8. Type C particles in mammary tumors of Friend leukemia virus-infected mice.
    Goldfeder A; de Harven E; Friend C
    Rev Eur Etud Clin Biol; 1971 Apr; 16(4):323-8. PubMed ID: 4327596
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonmalignancy of hybrids derived from two mouse malignant cells. I. Hybrids between L1210 leukemia cells and malignant L cells.
    Jami J; Ritz E
    J Natl Cancer Inst; 1973 Nov; 51(5):1647-53. PubMed ID: 4762938
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunofluorescent studies of mouse and hamster cell surface antigens induced by polyoma virus.
    Malmgren RA; Takemoto KK; Carney PG
    J Natl Cancer Inst; 1968 Feb; 40(2):263-8. PubMed ID: 4295609
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enhancement of immune response by an antitumor agent, cyclophosphamide].
    Nitta K; Tanaka T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):706-13. PubMed ID: 2938546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of polyacrylamide for cloning of primary tumors.
    Jones TL; Haskill JS
    Methods Cell Biol; 1976; 14():195-203. PubMed ID: 1004228
    [No Abstract]   [Full Text] [Related]  

  • 14. Serologically defined, unique surface antigen on a mouse mammary adenocarcinoma.
    Kuzumaki N; Klein G
    J Natl Cancer Inst; 1979 Mar; 62(3):619-22. PubMed ID: 84092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evidence of specific BCG-induced immunity to malignant melanoma in BALB-c mice.
    Faraci RP; Barone JJ; Marrone JC; Schour L
    J Natl Cancer Inst; 1974 Jun; 52(6):1913-5. PubMed ID: 4834418
    [No Abstract]   [Full Text] [Related]  

  • 16. Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E.
    Cianciolo GJ; Lostrom ME; Tam M; Snyderman R
    J Exp Med; 1983 Sep; 158(3):885-900. PubMed ID: 6193238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired immunological tolerance and carcinogenesis by the mammary tumor virus. I. Influence of neonatal infection with the mammary tumor virus on the growth of spontaneous mammary adenocarcinomas.
    Morton DL
    J Natl Cancer Inst; 1969 Feb; 42(2):311-20. PubMed ID: 4303883
    [No Abstract]   [Full Text] [Related]  

  • 18. Agglutination of in vitro cultured neoplastic and non-neoplastic cell lines by a wheat germ agglutinin.
    Gantt RR; Martin JR; Evans VJ
    J Natl Cancer Inst; 1969 Mar; 42(3):369-73. PubMed ID: 5777487
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimitotic agents and tumor regression.
    Nutini LG; Fardon JC; Poydock ME
    Oncology; 1974; 30(5):436-41. PubMed ID: 4462062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni.
    Hibbs JB; Lambert LH; Remington JS
    J Infect Dis; 1971 Dec; 124(6):587-92. PubMed ID: 5127071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.